Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Download PDF
June 28, 2016
/
News
Share
the Post
Related
Posts
Part 2: How is hepatitis C treated?
Asia-Pacific Aids Groups Express Deep Dismay At Conclusion Of Secretly Negotiated Trans-Pacific Partnership Agreement That Threatens Future Access To Affordable Generic Medicines And Sustainable Development Goals
Asia Pacific Situational Updates on Generic DAAs – June 2017
Read More
Story from Ajitshwor Wangkheirakpam, Manipur, India
APN+ joins MTAAG in congratulating Malaysia on sofosbuvir compulsory license
Up dated Generic Sofosbuvir availability and Price in India – 18 May 2015
Strategies to Secure Access to Generic HCV Medicines
Updated Generic Sofosbuvir Availability and Price in India 15 June 2015
